Athersys (NASDAQ:ATHX) Now Covered by StockNews.com

StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance The firm has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90. Athersys has a twelve month low […]

Leave a Reply

Your email address will not be published.

Previous post Stoke Therapeutics (NASDAQ:STOK) Price Target Raised to $47.00
Next post DMC Global (NASDAQ:BOOM) Lowered to “Sell” Rating by StockNews.com